Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial functional mapping of hypoxia inducible factor heterodimerisation and immune checkpoint regulators in clear cell renal cell carcinoma.

BJC reports·2024
Same author

DNA-PKcs is required for cGAS/STING-dependent viral DNA sensing in human cells.

iScience·2024
Same author

Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation.

Cancers·2022
Same author

The fusion of quantitative molecular proteomics and immune-oncology: a step towards precision medicine in cancer therapeutics.

FEBS letters·2022
Same author

Quantification of protein-protein interactions and activation dynamics: A new path to predictive biomarkers.

Biophysical chemistry·2022
Same author

The enigma of phosphoinositides and their derivatives: Their role in regulation of subcellular compartment morphology.

Biochimica et biophysica acta. Biomembranes·2021

Related Experiment Video

Updated: Apr 2, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K

Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas.

Emma Wagner1, Banafshé Larijani2, Amanda Robinson Kirane1

  • 1Division of General Surgery, Department of Surgery, Section of Surgical Oncology, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA 94305, USA.

Surgical Oncology Clinics of North America
|May 24, 2025
PubMed
Summary
This summary is machine-generated.

Predicting patient responses to immune checkpoint inhibitor (ICI) therapies for melanoma remains challenging. Novel spatial imaging can quantify tumor-immune interactions, aiding the development of predictive biomarkers for improved survival outcomes.

Keywords:
BiomarkerImmune checkpointImmunotherapyMelanomaPredictiveQuantitativeSpatial

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K

Related Experiment Videos

Last Updated: Apr 2, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.7K

Area of Science:

  • Oncology
  • Immunology
  • Biomarker Discovery

Background:

  • Predictive biomarkers for immune checkpoint inhibitor (ICI) therapy response in melanoma are lacking.
  • Current biomarkers are often prognostic, failing to capture complex tumor-immune dynamics crucial for ICI efficacy.
  • Novel spatial imaging platforms are needed to assess these interactions within the tumor microenvironment.

Purpose of the Study:

  • To address the unmet need for biomarkers predicting adverse responses to ICI therapies in melanoma patients.
  • To validate enhanced predictive biomarkers by quantifying immune checkpoint receptor-ligand interactions.
  • To inform biomarker selection by assessing changes in these interactions during neoadjuvant ICI treatment.

Main Methods:

  • Utilizing novel spatial imaging platforms to quantify immune checkpoint receptor-ligand interactions.
  • Analyzing these interactions at multiple time points during neoadjuvant ICI regimens.
  • Correlating changes in receptor-ligand interactions with patient survival data.

Main Results:

  • Spatial imaging enables quantification of critical immune checkpoint interactions.
  • Dynamic changes in receptor-ligand interactions during therapy can be monitored.
  • These dynamic changes show potential for correlating with patient survival outcomes.

Conclusions:

  • Enhanced predictive biomarkers are essential for optimizing ICI therapy in melanoma.
  • Spatial imaging offers a powerful tool for dissecting tumor-immune microenvironment dynamics.
  • Monitoring dynamic receptor-ligand interactions may lead to improved patient stratification and survival prediction.